Advancing Therapeutics Through Evidence-Based Engagement

Advancing Therapeutics Through Evidence-Based Engagement
Congredior:
A Latin word meaning "to meet," "to approach," "to engage."
PEO:
An abbreviation for "Patient Engagement Optimization."
CongrediorPEO:
Advancing Therapeutics Through Evidence-Based Engagement
CongrediorPEO is a strategic consultancy delivering data-driven patient engagement solutions to organizations across the pharmaceutical, biotech, clinical research, and patient advocacy sectors.
We specialize in amplifying the voice of the patient throughout the product lifecycle, from clinical trial design and pre-launch planning to post-launch marketing initiatives. Our approach ensures that patient perspectives are not only heard but meaningfully integrated into every stage of development and commercialization.
Through a selective alliance of subject-matter experts and strategic collaborators with more than 70 years of combined experience, we deliver scalable, specialized insights tailored to each engagement. This agile model enables our clients to navigate complex healthcare landscapes with clarity and confidence, while keeping patient-centered outcomes
at the forefront.
In our partnerships with patient advocacy organizations, we foster empathetic, evidence-based, and innovative approaches to industry engagement that amplify impact and drive measurable success.
In early clinical trial design, it is esssential to gain the perspectives and insights of the patients who will eventually enroll in a clinical trial. We initiate early-stage protocol reviews with patient populations to guide protocol developmet for optimum clinical trial recruitment success.
We excel at creating Patient Advisory Boards populated by patients and thought leaders. Insights from PABs are vital to clinical trial design and all patient-facing materials and media. Whether it is a global, national, or regional PAB, we mange every aspect of
in-person, remote, and hybrid meetings, working closely with clients' marketing/legal/regulatory processes.
From formulary preferences to packaging, patients provide critical insights into how a therapy can best meet the needs of end-users. Focus groups and surveys are important tools to gain critical insights that lead to successful treatment opportunities. We work with patient organizations and other thought leaders to recruit focus group members, as well as develop and disseminate surveys.
The voice of the patient is a powerful tool to help drug makers gain inroads into clinical trial enrollment, as well as pre- and post-launch awareness initiatives. Our expertise in recruiting and training patient ambassadors helps our clients gain critical exposure within their target patient population.
Working closely with our pharmaceutical/biotech clients, we help identify and prepare patient experts and thought leaders to provide input at FDA Patient Listening Sessions and other regulatory agency meetings.
Engaging with patient organizations that represent a particular disease cohort is key to successful engagement initiatives. The team at CongrediorPEO has more than 20 years of nonprofit management and engagement experience. Such experience makes our company the ideal partner to manage the intricacies of PO and pharmaceutical/biotech industry relations.
We proudly work with small and medium sized nonprofit patient organizations. We specialize in developing strategies and programs that prepare organizations to engage in patient-focused drug development partnerships with the pharmaceutical/biotech industry.
At CongrediorPEO, our values are based on the belief that the patient perspective is more than a data point, it’s direction. It guides our decisions, shapes our partnerships, and fuels our innovation. At the heart of everything we do is a belief in the power of collaboration, integrity, transparency, and patient-centered progress.
We believe that when drug development reflects the full spectrum of human diversity, science becomes more powerful, outcomes become more meaningful, and society becomes healthier.
With a deep commitment to inclusion, we work to ensure that every patient voice is heard, valued, and represented. We actively seek to engage participants from all walks of life, embracing differences in race, ethnicity, gender, age, and socioeconomic background.
We know that reducing barriers to participation is essential to building trust and driving progress. That is why we partner with pharmaceutical and biotech companies, CROs, patient organizations, and advocacy groups to create engagement strategies that are equitable, transparent, and transformative.
By listening deeply and acting boldly, we are dedicated to shaping a future where drug development mirrors the richness of humanity and unlocks innovations that lead to healthier futures.
CongrediorPEO is dedicated to advancing patient-focused drug development through customized, data-driven engagement initiatives. We unite pharmaceutical and biotech companies, clinical research organizations, and patient communities to amplify diverse voices, reduce barriers to participation, and build trust. Through equitable collaborations, we drive healthcare innovation for improved patient outcomes and a healthier society.
CongrediorPEO envisions a future where patient-focused drug development is consistently driven by measurable best practices in engagement strategies. By fostering trust and collaboration among all stakeholders in the drug development process, we strive to amplify diverse voices and transform healthcare innovation to achieve greater therapeutic opportunities and meaningful patient outcomes.
Leading the company's client relations, strategic partners, and subject-matter experts is Managing Director Robert J. Riggs. With three decades of expertise at the intersection of healthcare marketing, patient advocacy, and data-driven engagement programs, Robert has established a history of excellence in elevating patient perspectives from mere data points to transformational mandates.
A recognized authority in patient-centered strategy, Robert has developed and led high-impact initiatives across the nonprofit, pharmaceutical, biotech, and healthcare public relations sectors. His career is distinguished by a deep commitment to empathy, innovation, and measurable results, guiding organizations through strategic change, and forging global advocacy alliances.
With specialized knowledge in strategic communications, stakeholder engagement, and rare disease awareness, Robert is a trusted partner in navigating complex healthcare ecosystems with clarity and compassion.
Contact Robert at rriggs@congrediorpeo.com
We know that our clients have unique needs. Send us a message, and we will get back to you as soon as possible.
3104 East Camelback Road, Ste. 1238 | Phoenix, Arizona 85016 | USA
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.